Outcomes of minimal access retroperitoneal para-aortic lymphadenectomy in patients with locally advanced cervical cancer

Claire Newtona Gynaecology Oncology, University Hospitals Bristol NHS Foundation trust, Bristol, UK;b University of Bristol, Bristol, UK;c University College London Hospital NHS Foundation Trust, London, UKView further author information

Radha Grahamc University College London Hospital NHS Foundation Trust, London, UKView further author information

Viola Liberalec University College London Hospital NHS Foundation Trust, London, UKView further author information

Matthew Burnelld MRC Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UKView further author information

Usha Menond MRC Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UKView further author information

Tim Mouldc University College London Hospital NHS Foundation Trust, London, UKView further author information

Adeola Olaitanc University College London Hospital NHS Foundation Trust, London, UKView further author information

Nicola Macdonaldc University College London Hospital NHS Foundation Trust, London, UKView further author information

Martin Widschwendterc University College London Hospital NHS Foundation Trust, London, UK;e European Translational Oncology Prevention and Screening Institute, Leopold-Franzens-University of Innsbruck, AustriaView further author information

Kostas Doufekasc University College London Hospital NHS Foundation Trust, London, UKView further author information

Mary McCormackc University College London Hospital NHS Foundation Trust, London, UKView further author information

Anita Mitrac University College London Hospital NHS Foundation Trust, London, UKView further author information

Rupali Arorac University College London Hospital NHS Foundation Trust, London, UKView further author information

Ranjit Manchandad MRC Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK;f Wolfson Institute of Population Health, Queen Mary University of London, London, UK;g The Royal London hospital, Barts Health NHS trust, London, UK;h Distinguished Infosys Chair in Oncology, All India institute of medical sciences (AIIMS), New Delhi, IndiaCorrespondence[email protected]